Vaxcyte signs 15-year manufacturing deal with Thermo Fisher's Patheon

Vaxcyte, Inc.

Agreement covers formulation, fill, finish, testing at Patheon's Greenville, NC facility.
Binding minimum purchase commitments; termination fee in mid-eight-figures for convenience.
Initial 15-year term with auto-renewal; includes tech transfer and capex reimbursement.
Customary termination rights for cause, regulatory breach, or insolvency.

item 1.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.